14 Dec 2015

Reply

Enquiry// Virchow Biotech: APIs needed for the U.S. market [EN00215-EN00216-EN00217-EN00218-EN00219]
Virchow Biotech, part of the $200 million Virchow Group of Companies, equipped with facilities to manufacture products ranging from orals and topical biologicals, recombinants to parental bio-pharmaceuticals is starting development of Regadenoson, Docosanol, Azealic Acid, Fluocinonide & Desoximetasone for the U.S. market.

Comments :

nagavikas@msnlabs.com

Hi,
Are you still looking for Docosanol. I'm from Maithri Drugs Private Limited (MSN group) and we can help you out with this product.

Please contact us incase you need it.

18:21,  20 Jan 2018
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty